Patient
SITE012-0277
completed Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE012 (BRA) (Dr. Kowalski)
consented 2026-08-02
Adverse events
8
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 8
Grade 2 Rash — outcome: RECOVERED/RESOLVED; onset 2023-02-13 (study day 5); relationship: not assessed
Grade 2 Asthenia — outcome: RECOVERED/RESOLVED; onset 2023-02-10 (study day 2); relationship: not assessed
Grade 1 Constipation — outcome: RECOVERED/RESOLVED; onset 2023-02-10 (study day 2); relationship: not assessed
Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2023-02-10 (study day 2); relationship: not assessed
Grade 1 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-02-10 (study day 2); relationship: not assessed
Grade 1 Asthenia — outcome: RECOVERED/RESOLVED; onset 2023-02-10 (study day 2); relationship: NOT RELATED
Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2023-02-10 (study day 2); relationship: NOT RELATED
Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2023-02-10 (study day 2); relationship: NOT RELATED
Data queries 1
2 adverse event records for SITE012-0277 share preferred term Asthenia and onset 2026-08-17. Duplicate entry; the first record (entered 2026-08-17) is kept.
Auto-closed by AE-007 (duplicate AE record): first of 2 identical records kept; the 1 later copy flagged for the site to delete or differentiate.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.